Christopher & Dana Reeve Foundation

The Reeve Foundation’s NeuroRecovery Network (NRN) is a cooperative network of rehabilitation centers. Each member center is charged with developing and—more importantly—providing therapies that promote functional recovery and improve the health and overall quality of life for people living with paralysis.
https://www.christopherreeve.org/nrn

The mission of the North American Clinical Trials Network® (NACTN) is to bring promising therapies out of the laboratory and into clinical trials in a manner that provides strong evidence of effectiveness and safety.

NACTN supports a network of 10 clinical centers as well as clinical coordinating, data management and pharmacology sites, all dedicated to establishing best practices in the care and treatment of spinal cord injury (SCI).

By uniting experts across the country, NACTN conducts clinical trials that maximizes patient safety while gathering valid, meaningful data to speed the delivery of new therapies to the community.
In addition to translating discoveries from the lab into clinical studies, NACTN maintains a patient registry of information that is important to the design and testing of possible new treatments for SCI.
https://www.christopherreeve.org/research/nactn/about-nactn

The Reeve Foundation created the International Research Consortium on Spinal Cord Injury to forge a collaborative alliance among top neuroscience labs in the U.S. and abroad. The seven Consortium labs are run by scientists who, individually, have helped shape the field and made important contributions that form the basis for many potential treatments.
As a group, the principal investigators of the Consortium comprise a formidable team, combining their broad expertise and sharing their tools. The Consortium is also helping to launch the next generation of spinal cord scientists who will carry forward the Reeve Foundation mission.
https://www.christopherreeve.org/research